13F-HR filed by Casdin Capital, LLC
Casdin Capital, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 39 holding rows worth $1,502,747,643.
- Accession
- 0000919574-25-001518
- Filer
- CIK 1534261
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 39 entries on the cover page, a total value of $1,502,747,643 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,502,747,643 with VALUE read as dollars as filed, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 3,507,164 | $269,560,625 | dollars as filed | |
| BIOLIFE SOLUTIONS INC COM NEW | 09062W204 | Stock | 8,707,165 | $226,038,003 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 3,699,283 | $161,806,638 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,073,500 | $130,526,865 | dollars as filed | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 71,254,677 | $124,695,685 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 750,000 | $100,222,500 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 2,045,000 | $59,468,600 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 8,100,000 | $38,637,000 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 8,948,574 | $36,868,125 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 650,000 | $36,523,500 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 140,000 | $32,943,400 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,250,000 | $31,000,000 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 1,295,361 | $29,611,952 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 326,378 | $28,466,689 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 2,000,000 | $23,320,000 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 3,995,571 | $22,535,020 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 990,000 | $20,176,200 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 700,000 | $18,984,000 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 553,268 | $12,669,837 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 276,308 | $10,941,797 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 350,000 | $10,692,500 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 6,732,971 | $9,628,149 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 250,000 | $8,215,000 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 175,000 | $7,276,500 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 175,000 | $7,276,500 | dollars as filed | call |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 1,150,000 | $6,405,500 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 475,000 | $6,279,500 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 2,000,000 | $5,880,000 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 5,190,506 | $5,242,411 | dollars as filed | |
| FORTREA HLDGS INC COMMON STOCK | 34965K107 | Stock | 275,000 | $5,128,750 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 296,666 | $4,346,157 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,188,349 | $3,671,998 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 973,260 | $2,549,941 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 1,035,859 | $1,895,622 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 165,323 | $1,117,583 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 367,175 | $1,072,151 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 86,014 | $596,937 | dollars as filed | |
| GINKGO BIOWORKS HOLDINGS INC | 37611X209 | COMMON STOCK | 36,493 | $358,361 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 123,839 | $117,647 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-25-001518 | this filing | 2025-02-14 | acceptance time not in the bulk data set |